UK Markets open in 7 hrs 28 mins

EVOTEC SE (EVT.BE)

Berlin - Berlin Delayed price. Currency in EUR
Add to watchlist
23.70-0.57 (-2.35%)
At close: 09:55PM CEST
Full screen
Previous close24.27
Open24.32
Bid23.38 x 145200
Ask24.05 x 140700
Day's range23.37 - 24.32
52-week range20.39 - 45.70
Volume30
Avg. volume119
Market capN/A
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • EQS Group

    Evotec SE reports results of Annual General Meeting 2022

    DGAP-News: Evotec SE / Key word(s): AGM/EGMEvotec SE reports results of Annual General Meeting 2022 22.06.2022 / 16:20 The issuer is solely responsible for the content of this announcement. ALL AGENDA ITEMS ADOPTED WITH THE REQUIRED MAJORITY CAMILLA MACAPILI LANGUILLE ELECTED AS NEW MEMBER OF THE SUPERVISORY BOARD; KASIM KUTAY RESIGNS FROM SUPERVISORY BOARD AUTHORISED CAPITAL 2022 RESOLVED REVISED REMUNERATION SYSTEM FOR MANAGEMENT BOARD APPROVEDHamburg, Germany, 22 June 2022:Evotec SE (Frankfur

  • Zacks

    Evotec (EVO) Inks Drug Discovery Collaboration Deal With J&J

    Evotec (EVO) signs a collaboration agreement with Janssen, a wholly owned subsidiary of J&J, for discovering novel drugs in the field of protein homeostasis. Shares down.

  • EQS Group

    Evotec enters a drug discovery collaboration with Janssen

    DGAP-News: Evotec SE / Key word(s): MiscellaneousEvotec enters a drug discovery collaboration with Janssen 14.06.2022 / 07:30 The issuer is solely responsible for the content of this announcement. STRATEGIC PARTNERSHIP LEVERAGES EVOTEC’S PROPRIETARY PLATFORM CAPABILITIES IN THE FIELD OF PROTEIN HOMEOSTASISHamburg, Germany, 14 June 2022:Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) announced today that the Company has entered a drug discovery collaboratio